Unicycive Therapeutics Statistics
NASDAQ: UNCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.17+0.10 (+2.46%)
Market open · Delayed 15 min · as of Oct 9, 2:41 PM ET
Unicycive Therapeutics by the numbers
Unicycive Therapeutics has a market capitalization of $114.2 million based on 27.39M shares outstanding. With trailing EPS of $-1.72, Unicycive Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.0% below its 50-day average and 33.5% below its 200-day average.
Average daily trading volume is 839.29K shares, or about $3.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
UNCY valuation vs. peer median
| Metric | UNCY | Peer median | Difference |
|---|---|---|---|
| Market cap | $114.23M | $113.41M | +1% |
| Avg. volume | 839.29K | 487.96K | +72% |
Peer median across 8 companies: IMUX, RANI, GNLX, INO, CRBP, COYA, QUCY, CPIX.
Valuation
- Market cap
- $114.23M
- Forward P/E
- 2.47
- EPS (TTM)
- $-1.72
- Shares outstanding
- 27.39M
Price and trading
- Previous close
- 4.07
- Open
- 4.07
- Day range
- 4.05 – 4.17
- 52-week range
- 3.93 – 8.74
- 52-week change
- -14.68%
- Beta
- —
- Volume
- 294.38K
- Average volume
- 839.29K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 114.23M
- Forward Pe
- 2.47
- Eps
- -1.72
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.74
- Week52 Low
- 3.93
- Avg Volume
- 839.29K
- Shares Outstanding
- 27.39M
- Ma50
- 5.03
- Ma200
- 6.28
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -52.29%
- Pct From52w Low
- 6.11%